Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Manager, FP&A will be the FP&A business partner to our G&A departments and support our growing needs in R&D Finance. This role will also assist with performing company-wide reporting and managing the FP&A planning software.
-
Supporting and serving as the financial G&A business partner for our Commercial, Legal, Finance, HR, Facilities, and IT teams
-
Work cross-functionally with R&D Business partners including Biology and Chemistry
-
Prepare monthly variance analysis of actuals to forecast and budget, explain, and investigate any major discrepancies, and understand key business drivers.
-
Play key role in preparing monthly internal financial management reporting package.
-
Work closely with accounting to forecast and track activities for internal functions including tracking headcount and CAPEX purchases.
-
Maintain reporting tools to report and communicate company’s financial metrics, including the team’s financial planning software (Adaptive Insights)
-
Support annual budget and forecasting process, including budget and forecast template preparation, perform additional analyses that support budget and forecasting needs and prepare PowerPoint slides as needed.
-
Review purchase requests against budgeted amount and account coding
-
Help drive process improvements and efficiencies in areas of financial planning, financial analysis, and production of reporting packages.
-
Support monthly accounting close process.
-
Ad hoc reporting and analysis, as needed.
Required Experience, Skills and Education:
-
Bachelor’s degree in finance, Accounting, or related field
-
CPA or MBA preferred.
-
4+ years’ experience in similar role in biotechnology industry
-
Highly proficient in Excel and PowerPoint
-
Demonstrated experience utilizing financial systems and other business intelligence tools; Sage Intaact, Adaptive Insights (including OfficeConnect), and Coupa experience a plus.
-
Experience working effectively in a fast-paced environment with minimal direction.
-
Strong work ethic and ability to adjust workload based on changing priorities.
-
Highest standards of accuracy, precision, and attention to detail; highly organized
-
Ability to think creatively, highly driven, and initiative-taking.
Preferred Skills:
-
Ability to work cross-functionally effectively and collaboratively with demonstrated ability to multi-task, prioritize options, anticipate challenges, and execute corporate goals.
-
Strong analytical and advanced excel skills as well as excellent written and verbal communication skills.
The expected salary range for this role is $136,000 to $165,000. An individual’s position within the range may be influenced by multiple factors, including skills and experience in role, overall performance, individual impact and contributions, tenure, and market dynamics. Base salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
#LI-Hybrid #LI-DN1